help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on September 1, 2005, doi:10.1165/rcmb.2005-0050OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-0050OCv1
33/6/622    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cho, S. J.
Right arrow Articles by Acarregui, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cho, S. J.
Right arrow Articles by Acarregui, M. J.
American Journal of Respiratory Cell and Molecular Biology. Vol. 33, pp. 622-628, 2005
© 2005 American Thoracic Society
DOI: 10.1165/rcmb.2005-0050OC

Retinoic Acid and Erythropoietin Maintain Alveolar Development in Mice Treated with an Angiogenesis Inhibitor

Su Jin Cho, Caroline L. S. George, Jeanne M. Snyder and Michael J. Acarregui

Roy J. and Lucille A. Carver College of Medicine, University of Iowa; and Department of Pediatrics, Department of Anatomy and Cell Biology, University of Iowa College of Medicine, Iowa City, Iowa

Correspondence and requests for reprints should be addressed to Michael J. Acarregui, M.D., Department of Pediatrics, Carver College of Medicine, University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242. E-mail: michael-acarregui{at}uiowa.edu

Bronchopulmonary dysplasia in premature infants is characterized by inhibited alveolarization and vasculogenesis. Our goal was to generate a mouse model of inhibited alveolarization by the administration of an inhibitor of angiogenesis. We then examined the effects of retinoic acid (RA) and erythropoietin (EPO) on alveolar development in this model. Three-day-old mice were injected with a single dose of SU1498 (30 mg/kg, subcutaneously) and either concomitant RA (2 mg/kg, intraperitoneally) or EPO (2,000 IU/kg, subcutaneously) for 10 consecutive days, then harvested on Day 21. Morphometric and electron microscopic analysis, and platelet endothelial cell adhesion molecule (PECAM) immunostaining of endothelial cells, were performed on the lung tissue. In vitro assays were also performed to characterize the effects of RA on endothelial cell growth. Alveolar development was attenuated in the SU1498-treated mice, and electron microscopy demonstrated dilated and dysmorphic capillaries in alveolar walls comparable to previous findings in lungs of infants with bronchopulmonary dysplasia. RA or EPO maintained mean alveolar volume, alveolar surface area, and endothelial cell volume density in the SU1498-treated animals. RA also increased the proliferation of human fetal lung capillary endothelial precursor cells in vitro. These results suggest that the maintenance or growth of the endothelial cell population of the distal lung plays a major role in postnatal alveolar development.

Key Words: alveolar development • erythropoietin • retinoic acid • SU1498 • angiogenesis inhibition




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
Q. Zhang, J. Zhang, O. W. Moe, and C. C. W. Hsia
Synergistic upregulation of erythropoietin receptor (EPO-R) expression by sense and antisense EPO-R transcripts in the canine lung
PNAS, May 27, 2008; 105(21): 7612 - 7617.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
E. J Su, Y.-H. Cheng, R. T Chatterton, Z.-H. Lin, P. Yin, S. Reierstad, J. Innes, and S. E Bulun
Regulation of 17-Beta Hydroxysteroid Dehydrogenase Type 2 in Human Placental Endothelial Cells
Biol Reprod, September 1, 2007; 77(3): 517 - 525.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2005 American Thoracic Society.